From the archive: Parkinson’s funder steps up

A clear path to patient benefit is crucial for success at Cure Parkinson’s

Cure Parkinson’s, one of the UK’s younger medical research charities, was launched in 2005 with the goal of clinical impact firmly in mind. That remains the case to this day, and the charity acknowledges that most of the projects it supports are “focused on the repurposing of existing drugs, the acceleration of new pharmacological agents and the development of regenerative therapies”.

Nonetheless, basic research bids that are relevant to Parkinson’s disease will be considered—but, as Leah Mursaleen, research manager at Cure Parkinson’s, related in this interview published in March 2021, the pathway to clinical impact must be outlined with complete conviction and clarity.